Epigenetic profiling by near-field UV-Raman scattering in nanochannels
通过纳米通道中的近场紫外拉曼散射进行表观遗传分析
基本信息
- 批准号:7934441
- 负责人:
- 金额:$ 19.31万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-09-18 至 2011-08-31
- 项目状态:已结题
- 来源:
- 关键词:AchievementAntibodiesArtsBase CompositionCellsChromatinChromatin ModelingChromosomesCytosineDNADNA BindingDataData QualityDetectionDevelopmentDevicesDyesEnvironmental Risk FactorEpigenetic ProcessEvolutionFigs - dietaryFluorescenceFungal GenomeGC Rich SequenceGenesGeneticGenetic MaterialsGenomicsGoalsHaploidyHaplotypesHistonesHuman GenomeHybridsImageryIndividualLabelLibrariesLocationMalignant NeoplasmsMapsMeasuresMetalsMethodsMethylationModelingModificationMolecular AnalysisMonitorNatureNeoplasm MetastasisOpticsPopulationProcessPropertyResearchResolutionScanningSignal TransductionStagingStem cellsStretchingStructureSurfaceTechniquesTechnologyTestingUrsidae FamilyYeastsanticancer researchcancer stem cellchromatin modificationdriving forcegenome sequencinggenome-widehistone modificationimprovednanochannelnanofluidicperformance testsprogramsreconstitutionsingle moleculetooltumor
项目摘要
DESCRIPTION (provided by applicant): Epigenetic programming has emerged as a central theme in cancer development. Here we propose a new technique for monitoring the methylation state, chromatin status, and histone modification of genomic sized molecules, ideally whole chromosomes. The proposed method combines stretching of genetic material in nanofluidic channels, and subsequent optical readout by UV-resonant Raman scattering under near-field enhancement. We expect a resolution of about 1 kbp or better. The technique will provide a tool for single-molecule studies probing the epigenetic diversity of cell populations, and should be able to yield information about the importance and evolution of progenitor cell within tumors. The proposed research is exploratory in nature, but will provide significant improvements over the current art because of its capability to handle long molecules, high resolution, and label-free detection. Our strategy toward our goal is to establish a number of milestones along the way, which by themselves are significant achievements. In the first stage, we will nanochannel stretching of DNA that is labeled using methylation-specific fluorescent markers. We also aim at demonstrating chromatin stretching, and visualization of histones using specific antibodies. In the next stage, we will demonstrate that near-field enhancement of fluorescence by metal structures that are integrated with the nanofluidic device. The resolution should improve by a factor of 10. We will then investigate the near-field UV-resonant Raman signatures of specific DNA and chromatin constructs on test structures on wafers. Finally, we will integrate our findings to demonstrate near-field UV-resonant Raman of DNA scanned through nanochannels. Further, we will use the best technology proven in the course of the project, Raman or fluorescence, chromatin or bare DNA, to construct an epigenetic map of genomic model DNA or reconstituted chromatin from yeasts. We propose a new technique for monitoring the epigenetic programming state of genomic sized molecules, ideally whole chromosomes. The proposed method combines stretching of genetic material in nanofluidic channels, and subsequent optical readout by UV-resonant Raman scattering under near-field enhancement. We expect the method to become a valuable tool in cancer research.
描述(由申请人提供):表观遗传编程已成为癌症发展的中心主题。在这里,我们提出了一种新的技术,用于监测甲基化状态,染色质状态,和组蛋白修饰的基因组大小的分子,理想的是整个染色体。所提出的方法结合了纳米流体通道中的遗传物质的拉伸,以及随后通过近场增强下的UV共振拉曼散射的光学读出。我们希望分辨率约为1 kbp或更高。该技术将为探索细胞群体表观遗传多样性的单分子研究提供工具,并应能够产生有关肿瘤内祖细胞重要性和进化的信息。拟议的研究本质上是探索性的,但由于其处理长分子、高分辨率和无标记检测的能力,将提供对现有技术的重大改进。我们实现目标的战略是在这条道路上沿着建立一些里程碑,这些里程碑本身就是重大成就。在第一阶段,我们将使用甲基化特异性荧光标记物标记的DNA的纳米通道拉伸。我们的目标也是展示染色质的拉伸,以及使用特异性抗体的组蛋白的可视化。在下一阶段,我们将证明与纳米流体装置集成的金属结构的近场荧光增强。分辨率应提高10倍。然后,我们将研究近场紫外共振拉曼签名的特定DNA和染色质结构上的测试结构的晶片。最后,我们将整合我们的研究结果,以证明近场紫外共振拉曼的DNA扫描通过纳米通道。此外,我们将使用在项目过程中证明的最佳技术,拉曼或荧光,染色质或裸DNA,构建基因组模型DNA或来自酵母的重组染色质的表观遗传图谱。我们提出了一种新的技术,用于监测基因组大小的分子,理想的是整个染色体的表观遗传编程状态。所提出的方法结合了纳米流体通道中的遗传物质的拉伸,以及随后通过近场增强下的UV共振拉曼散射的光学读出。我们希望这种方法能成为癌症研究中一种有价值的工具。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Hans Hallen其他文献
Hans Hallen的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Hans Hallen', 18)}}的其他基金
Epigenetic profiling by near-field UV-Raman scattering in nanochannels
通过纳米通道中的近场紫外拉曼散射进行表观遗传分析
- 批准号:
8193129 - 财政年份:2009
- 资助金额:
$ 19.31万 - 项目类别:
Epigenetic profiling by near-field UV-Raman scattering in nanochannels
通过纳米通道中的近场紫外拉曼散射进行表观遗传分析
- 批准号:
7694949 - 财政年份:2009
- 资助金额:
$ 19.31万 - 项目类别:
相似海外基金
University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
- 批准号:
10073243 - 财政年份:2024
- 资助金额:
$ 19.31万 - 项目类别:
Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
- 批准号:
10752129 - 财政年份:2024
- 资助金额:
$ 19.31万 - 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
- 批准号:
2339201 - 财政年份:2024
- 资助金额:
$ 19.31万 - 项目类别:
Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
- 批准号:
MR/Y008693/1 - 财政年份:2024
- 资助金额:
$ 19.31万 - 项目类别:
Research Grant
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
- 批准号:
10076445 - 财政年份:2023
- 资助金额:
$ 19.31万 - 项目类别:
Grant for R&D
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
- 批准号:
23K14783 - 财政年份:2023
- 资助金额:
$ 19.31万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
- 批准号:
23KJ0394 - 财政年份:2023
- 资助金额:
$ 19.31万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Role of antibodies in hepatitis E virus infection
抗体在戊型肝炎病毒感染中的作用
- 批准号:
10639161 - 财政年份:2023
- 资助金额:
$ 19.31万 - 项目类别:
Defining the protective or pathologic role of antibodies in Post-Ebola Syndrome
定义抗体在埃博拉后综合症中的保护或病理作用
- 批准号:
10752441 - 财政年份:2023
- 资助金额:
$ 19.31万 - 项目类别:
Human CMV monoclonal antibodies as therapeutics to inhibit virus infection and dissemination
人 CMV 单克隆抗体作为抑制病毒感染和传播的治疗药物
- 批准号:
10867639 - 财政年份:2023
- 资助金额:
$ 19.31万 - 项目类别: